AllianceBernstein’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.79M | Buy |
73,349
+17,412
| +31% | +$836K | ﹤0.01% | 1701 |
|
|
2026
Q1 | $2.78M | Buy |
55,937
+1,845
| +3% | +$94K | ﹤0.01% | 1821 |
|
|
2025
Q4 | $2.69M | Buy |
54,092
+30
| +0.1% | +$1.46K | ﹤0.01% | 1841 |
|
|
2025
Q3 | $2.58M | Buy |
54,062
+600
| +1% | +$24.2K | ﹤0.01% | 1865 |
|
|
2025
Q2 | $1.69M | Sell |
53,462
-609
| -1% | -$19.5K | ﹤0.01% | 2030 |
|
|
2025
Q1 | $1.77M | Sell |
54,071
-91
| -0.2% | -$3.23K | ﹤0.01% | 1973 |
|
|
2024
Q4 | $1.96M | Buy |
54,162
+152
| +0.3% | +$5.35K | ﹤0.01% | 1967 |
|
|
2024
Q3 | $1.68M | Sell |
54,010
-3,100
| -5% | -$96.8K | ﹤0.01% | 2054 |
|
|
2024
Q2 | $1.53M | Hold |
57,110
| – | – | ﹤0.01% | 2094 |
|
|
2024
Q1 | $1.95M | Sell |
57,110
-2,790
| -5% | -$83.1K | ﹤0.01% | 1938 |
|
|
2023
Q4 | $1.73M | Sell |
59,900
-2,918
| -5% | -$77.4K | ﹤0.01% | 2016 |
|
|
2023
Q3 | $1.73M | Hold |
62,818
| – | – | ﹤0.01% | 1963 |
|
|
2023
Q2 | $1.89M | Sell |
62,818
-8
| -0% | -$280 | ﹤0.01% | 1929 |
|
|
2023
Q1 | $2.28M | Sell |
62,826
-7,970
| -11% | -$306K | ﹤0.01% | 1792 |
|
|
2022
Q4 | $2.53M | Sell |
70,796
-2,470
| -3% | -$85.8K | ﹤0.01% | 1782 |
|
|
2022
Q3 | $2.48M | Buy |
73,266
+4,161
| +6% | +$135K | ﹤0.01% | 1746 |
|
|
2022
Q2 | $2M | Sell |
69,105
-3,794
| -5% | -$109K | ﹤0.01% | 1956 |
|
|
2022
Q1 | $2.36M | Buy |
72,899
+176
| +0.2% | +$5.4K | ﹤0.01% | 1988 |
|
|
2021
Q4 | $2.12M | Buy |
72,723
+93
| +0.1% | +$2.82K | ﹤0.01% | 2111 |
|
|
2021
Q3 | $1.94M | Sell |
72,630
-6,850
| -9% | -$184K | ﹤0.01% | 2189 |
|
|
2021
Q2 | $2.45M | Buy |
79,480
+5,424
| +7% | +$166K | ﹤0.01% | 2067 |
|
|
2021
Q1 | $1.94M | Sell |
74,056
-23,880
| -24% | -$668K | ﹤0.01% | 2122 |
|
|
2020
Q4 | $2.46M | Buy |
97,936
+24,996
| +34% | +$538K | ﹤0.01% | 1857 |
|
|
2020
Q3 | $1.52M | Sell |
72,940
-1,410
| -2% | -$32K | ﹤0.01% | 1989 |
|
|
2020
Q2 | $1.77M | Buy |
74,350
+2,160
| +3% | +$47.7K | ﹤0.01% | 1911 |
|
|
2020
Q1 | $1.3M | Buy |
72,190
+100
| +0.1% | +$2.1K | ﹤0.01% | 1913 |
|
|
2019
Q4 | $1.71M | Sell |
72,090
-64,870
| -47% | -$1.58M | ﹤0.01% | 2048 |
|
|
2019
Q3 | $3.76M | Sell |
136,960
-11,900
| -8% | -$353K | ﹤0.01% | 1567 |
|
|
2019
Q2 | $4.93M | Buy |
148,860
+21,300
| +17% | +$730K | ﹤0.01% | 1425 |
|
|
2019
Q1 | $4.47M | Hold |
127,560
| – | – | ﹤0.01% | 1444 |
|
|
2018
Q4 | $4.24M | Sell |
127,560
-400
| -0.3% | -$17.2K | ﹤0.01% | 1379 |
|
|
2018
Q3 | $6.44M | Hold |
127,960
| – | – | ﹤0.01% | 1150 |
|
|
2018
Q2 | $7.66M | Buy |
127,960
+20,520
| +19% | +$1.06M | 0.01% | 1068 |
|
|
2018
Q1 | $4.92M | Sell |
107,440
-5,770
| -5% | -$241K | ﹤0.01% | 1226 |
|
|
2017
Q4 | $4.51M | Hold |
113,210
| – | – | ﹤0.01% | 1278 |
|
|
2017
Q3 | $4.53M | Sell |
113,210
-19,530
| -15% | -$845K | ﹤0.01% | 1268 |
|
|
2017
Q2 | $5.72M | Sell |
132,740
-17,870
| -12% | -$636K | ﹤0.01% | 1148 |
|
|
2017
Q1 | $4.71M | Sell |
150,610
-87,600
| -37% | -$2.35M | ﹤0.01% | 1225 |
|
|
2016
Q4 | $6.01M | Buy |
238,210
+17,780
| +8% | +$397K | 0.01% | 1092 |
|
|
2016
Q3 | $5.45M | Buy |
220,430
+91,360
| +71% | +$2.07M | ﹤0.01% | 1084 |
|
|
2016
Q2 | $2.63M | Buy |
129,070
+57,200
| +80% | +$1.01M | ﹤0.01% | 1482 |
|
|
2016
Q1 | $1.1M | Buy |
71,870
+15,730
| +28% | +$205K | ﹤0.01% | 2038 |
|
|
2015
Q4 | $755K | Sell |
56,140
-6,100
| -10% | -$94.4K | ﹤0.01% | 2271 |
|
|
2015
Q3 | $873K | Buy |
62,240
+1,540
| +3% | +$28.6K | ﹤0.01% | 2236 |
|
|
2015
Q2 | $1.03M | Sell |
60,700
-72,570
| -54% | -$1.03M | ﹤0.01% | 2261 |
|
|
2015
Q1 | $1.61M | Buy |
133,270
+129,070
| +3,073% | +$1.22M | ﹤0.01% | 1889 |
|
|
2014
Q4 | $35K | Sell |
4,200
-4,200
| -50% | -$35.3K | ﹤0.01% | 3153 |
|
|
2014
Q3 | $73K | Hold |
8,400
| – | – | ﹤0.01% | 3025 |
|
|
2014
Q2 | $92K | Buy |
8,400
+7,692
| +1,086% | +$68.5K | ﹤0.01% | 3012 |
|
|
2014
Q1 | $6K | Sell |
708
-4,600
| -87% | -$42.4K | ﹤0.01% | 3328 |
|
|
2013
Q4 | $40K | Sell |
5,308
-6,800
| -56% | -$47.5K | ﹤0.01% | 3019 |
|
|
2013
Q3 | $89K | Sell |
12,108
-3,418
| -22% | -$23K | ﹤0.01% | 2992 |
|
|
2013
Q2 | $100K | Buy |
+15,526
| New | +$91.4K | ﹤0.01% | 2949 |
|
Other funds holding SUPN
AC
NAMI
SIMG
AllianceBernstein's SUPN Position: Q2 2026 in Review
AllianceBernstein increased its Supernus Pharmaceuticals (SUPN) stake by 31% in Q2 2026, buying an estimated $836K and bringing the position to 73,349 shares worth $3.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1701.
AllianceBernstein first reported a position in SUPN in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.66M in Q2 2018. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- AllianceBernstein held 73,349 shares of Supernus Pharmaceuticals worth $3.79M as of Q2 2026.
- AllianceBernstein bought 17,412 Supernus Pharmaceuticals shares in Q2 2026, an estimated $836K.
- Supernus Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1701 holding.
- AllianceBernstein first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- AllianceBernstein's Supernus Pharmaceuticals position peaked at $7.66M in Q2 2018.
- 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.